These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36435654)

  • 21. Differentiation of bullous pemphigoid from epidermolysis bullosa acquisita on frozen skin biopsies.
    Valeski JE; Kumar V; Beutner EH; Cartone C; Kasprzyk K
    Int J Dermatol; 1992 Jan; 31(1):37-41. PubMed ID: 1737687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita).
    Ujiie H; Iwata H; Yamagami J; Nakama T; Aoyama Y; Ikeda S; Ishii N; Iwatsuki K; Kurosawa M; Sawamura D; Tanikawa A; Tsuruta D; Nishie W; Fujimoto W; Amagai M; Shimizu H;
    J Dermatol; 2019 Dec; 46(12):1102-1135. PubMed ID: 31646663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
    Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermolysis bullosa acquisita localized to the face.
    Choi GS; Lee ES; Kim SC; Lee S
    J Dermatol; 1998 Jan; 25(1):19-22. PubMed ID: 9519604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
    Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
    Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.
    Kirtschig G; Murrell D; Wojnarowska F; Khumalo N
    Arch Dermatol; 2002 Mar; 138(3):380-4. PubMed ID: 11902989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
    Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
    J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bullous Pemphigoid and Other Pemphigoid Dermatoses.
    Pratasava V; Sahni VN; Suresh A; Huang S; Are A; Hsu S; Motaparthi K
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blistering disorders: diagnosis and treatment.
    Yeh SW; Ahmed B; Sami N; Razzaque Ahmed A
    Dermatol Ther; 2003; 16(3):214-23. PubMed ID: 14510878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physiopathology of autoimmune bullous dermatoses of the basement membrane].
    Salmon-Ehr V; Bernard P
    Ann Dermatol Venereol; 1998 Nov; 125(11):817-23. PubMed ID: 9856264
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
    Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
    Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced cicatricial pemphigoid and acquired epidermolysis bullosa.
    Van Joost T; Van't Veen AJ
    Clin Dermatol; 1993; 11(4):521-7. PubMed ID: 8124642
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.
    Ghorbanalipoor S; Emtenani S; Parker M; Kamaguchi M; Osterloh C; Pigors M; Gross N; Khil'chenko S; Kasprick A; Patzelt S; Wortmann D; Ibrahim IO; Izumi K; Goletz S; Boch K; Kalies K; Bieber K; Smith P; Schmidt E; Ludwig RJ
    Front Immunol; 2022; 13():865241. PubMed ID: 36248903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bullous autoimmune dermatoses of the mucous membranes].
    Didona D; Hinterseher J; Eming R
    Dermatologie (Heidelb); 2022 Sep; 73(9):692-700. PubMed ID: 36006424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular involvement in anti-epiligrin cicatricial pemphigoid.
    Nischler C; Sadler E; Lazarova Z; Stoiber J; Ruckhofer J; Pohla-Gubo G; Emberger M; Bauer JW; Grabner G; Hintner H
    Eur J Ophthalmol; 2006; 16(6):867-9. PubMed ID: 17191196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the alpha 6 beta 4 integrin in lesional skin differentiates bullous pemphigoid (BP) from epidermolysis bullosa acquisita (EBA).
    Michalaki H; Staquet MJ; Cerri A; Berti E; Roche P; Machado P; Nicolas JF
    J Invest Dermatol; 1992 Feb; 98(2):204-8. PubMed ID: 1732384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Involvement of mucous membranes in autoimmune bullous diseases].
    Günther C
    Hautarzt; 2016 Oct; 67(10):774-779. PubMed ID: 27631412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum eosinophil cationic protein (ECP) in bullous pemphigoid.
    Caproni M; Palleschi GM; Falcos D; D'Agata A; Cappelli G; Fabbri P
    Int J Dermatol; 1995 Mar; 34(3):177-80. PubMed ID: 7751092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.